Tau radiotracers for Baltimore Longitudinal Study of Aging

The National Institutes of Health (NIH) issued a Sources Sought notice to gauge interest from qualified small businesses for supplying FDA‑approved second‑generation tau PET imaging radiotracers ([18F]MK‑6240) for the Baltimore Longitudinal Study of Aging. The procurement will cover a base period of 70 radiotracer doses and two optional years of equal quantity, totaling up to 210 doses over three years. Respondents must demonstrate capability to deliver the product on schedule, state their small‑business status, and provide relevant corporate and technical information. • Provide 70 doses for the base year (Nov 18 2026 – Nov 17 2027) and up to 70 doses each for two optional years. • Must be a small business (including HUBZone, SDVOSB, 8(a), woman‑owned, etc.) and meet NAICS 325414 criteria. • Submit a detailed response (product literature, capability statement, DUNS, size status) electronically to Contracting Officer Kevin Alvarez by Oct 27 2026, 9:00 AM ET.